Drug class
Coumarin anticoagulant; vitamin K antagonist
Mechanism of action
Inhibits vitamin K epoxide reductase, reducing regeneration of active vitamin K. This decreases gamma-carboxylation and functional activation of coagulation factors II, VII, IX and X and anticoagulant proteins C and S.
General use cases
- Prevention and treatment of thromboembolic disorders, including venous thrombosis and pulmonary embolism, under the relevant product information and INR-monitoring requirements.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
